zensun.com
泽生科技上海泽生科技开发有限公司是一家以国际医药市场需求为主导、以创新研究为基础、具有重大获利潜力的生物高科技医药企业，致力于具有自主知识产权的原创新药开发研究。秉承
http://www.zensun.com/
上海泽生科技开发有限公司是一家以国际医药市场需求为主导、以创新研究为基础、具有重大获利潜力的生物高科技医药企业，致力于具有自主知识产权的原创新药开发研究。秉承
http://www.zensun.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
5.2 seconds
DOMAIN WHOIS PROTECTION SERVICE
WHOIS AGENT
3/F.,HiChina Mansion,No.27 ●●●●●●●●●●●●●●●●●●●●●●●●●●●strict,Beijing 100120,China
Be●●ng , Beijing, 100120
CN
View this contact
DOMAIN WHOIS PROTECTION SERVICE
WHOIS AGENT
3/F.,HiChina Mansion,No.27 ●●●●●●●●●●●●●●●●●●●●●●●●●●●strict,Beijing 100120,China
Be●●ng , Beijing, 100120
CN
View this contact
DOMAIN WHOIS PROTECTION SERVICE
WHOIS AGENT
3/F.,HiChina Mansion,No.27 ●●●●●●●●●●●●●●●●●●●●●●●●●●●strict,Beijing 100120,China
Be●●ng , Beijing, 100120
CN
View this contact
DOMAIN WHOIS PROTECTION SERVICE
WHOIS AGENT
3/F.,HiChina Mansion,No.27 ●●●●●●●●●●●●●●●●●●●●●●●●●●●strict,Beijing 100120,China
Be●●ng , Beijing, 100120
CN
View this contact
BUY YOUR DOMAIN
22
YEARS
8
MONTHS
26
DAYS
HICHINA ZHICHENG TECHNOLOGY LTD.
WHOIS : grs-whois.hichina.com
REFERRED : http://www.net.cn
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
14
SITE IP
121.198.207.52
LOAD TIME
5.207 sec
SCORE
6.2
泽生科技 | zensun.com Reviews
https://zensun.com
上海泽生科技开发有限公司是一家以国际医药市场需求为主导、以创新研究为基础、具有重大获利潜力的生物高科技医药企业，致力于具有自主知识产权的原创新药开发研究。秉承
zensun.com
泽生科技
http://www.zensun.com/center/index_10.aspx
联系电话 86-21-50802627 传真 86-21-50802621. 今日访问量 43 总访问量 484571.
泽生科技
http://www.zensun.com/center/index_8.aspx
该项目目前处于临床前研究阶段，计划申报化药1.6类 新适应症 ，即将启动临床试验。 联系电话 86-21-50802627 传真 86-21-50802621. 今日访问量 45 总访问量 484573.
泽生科技
http://www.zensun.com/news/index.aspx
纽兰格林美国 Phase II 临床数据喜人. 联系电话 86-21-50802627 传真 86-21-50802621. 今日访问量 40 总访问量 484568.
泽生科技
http://www.zensun.com/index.aspx
Recombinant human neuregulin-1(NEUCARDIN : rhNRG-1). 联系电话 86-21-50802627 传真 86-21-50802621. 今日访问量 44 总访问量 484572.
泽生科技
http://www.zensun.com/center/index_4.aspx
联系电话 86-21-50802627 传真 86-21-50802621. 今日访问量 42 总访问量 484570.
TOTAL PAGES IN THIS WEBSITE
20
Zensun USA Inc.
http://www.zensunusa.com/about/index.aspx
US clinical trial of rhNRG-1 is enrolling heart failure patients with NYHA Classification II and III.
Zensun USA Inc.
http://www.zensunusa.com/news/developments.aspx
Zensun Announces Successful End of Phase 2 Meeting for Neucardin. SHANGHAI, CHINA and SAN DIEGO, USA, January 4, 2014 Zensun (Shanghai) Sci. and Tech., Ltd, and its subsidiary Zensun USA, Inc. are. Zensun Announces Positive Results for Neucardin to Improve Heart Func. Zensun Obtained the Exciting Results of US Phase II Clinical Trial. Phase II Clinical Trial of rhNRG-1 is Near Completion. Zensun has Submitted NDA of rhNRG-1 to SFDA. Anti-Heart Failure Drug - rhNRG-1 has Completed Chinese Phase II Clini.
Zensun USA Inc.
http://www.zensunusa.com/about
US clinical trial of rhNRG-1 is enrolling heart failure patients with NYHA Classification II and III.
Zensun USA Inc.
http://www.zensunusa.com/about/index3.aspx
Professor Paul M.G. Vanhoutte, MD., Ph.D., Chairman, Scientific Advisory Board. Kenneth Chien, M.D., Ph.D., Advisor, Scientific Advisory Board. Professor Robert M. Graham, MD., Ph.D., Advisor, Scientific Advisory Board. Dr Charles Antzelevitch, Ph.D., Advisor, Scientific Advisory Board. Dr Barry Greenburg, MD., Advisor, Scientific Advisory Board. Prof Runlin Gao, Advisor, Scientific Advisory Board. US clinical trial of rhNRG-1 is enrolling heart failure patients with NYHA Classification II and III.
Zensun USA Inc.
http://www.zensunusa.com/about/index4.aspx
David Charapp B.S. J.D. David obtained his J.D from Boston College Law School and his B.S. in Business Administration from the University of North Carolina at Chapel Hill. Having previously worked in a number of biotechnology companies and as an associate at Foley and Lardner, he is now a partner at Duane Morris LLP where he helps Zensun USA, Inc. with business development and U.S. Clinical Operations. US clinical trial of rhNRG-1 is enrolling heart failure patients with NYHA Classification II and III.
Zensun USA Inc.
http://www.zensunusa.com/clinicaltrials
Zensun is developing a novel treatment for Chronic Heart Failure (CHF), a syndrome where the heart is unable to supply sufficient blood flow to meet the needs of the body. It is estimated that the prevalence of CHF is 5.3 million people in the United States with 550,000 new cases reported each year. Neucardin has been given to 1000 subjects with CHF and over 1500 people have been involved in 16 clinical trials in China, Australia and the United States.
Zensun USA Inc.
http://www.zensunusa.com/about/index2.aspx
Zhenggang Jiang, Ph.D., CEO. Steven A. Kradjian. Solomon Tse Ph.D Chemistry Manufacturing and Controls (CMC). For Amylin and MEPACT which is currently in sales in Europe. Dr. Tse has a Biochemistry doctoral degree from the University of Missouri. US clinical trial of rhNRG-1 is enrolling heart failure patients with NYHA Classification II and III.
Zensun USA Inc.
http://www.zensunusa.com/clinicaltrials/index.aspx
Zensun is developing a novel treatment for Chronic Heart Failure (CHF), a syndrome where the heart is unable to supply sufficient blood flow to meet the needs of the body. It is estimated that the prevalence of CHF is 5.3 million people in the United States with 550,000 new cases reported each year. Neucardin has been given to 1000 subjects with CHF and over 1500 people have been involved in 16 clinical trials in China, Australia and the United States.
Zensun USA Inc.
http://www.zensunusa.com/index.aspx
An International Multi-center Phase III Clinical Trial of Recombinant Human Neuregulin-1 is going to Launch. Zensun is a biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical. Zensun Announces Successful End of Phase 2 Meeting for Neucardin. SHANGHAI, CHINA and SAN DIEGO, USA, January 4, 2014 Zensun (Sha. Zensun Announces Positive Results for Neucardin to Improve Heart.
Zensun USA Inc.
http://www.zensunusa.com/clinicaltrials/index2.aspx
Sorry, the Clinical Trials ParticipantsRecruiting has finished at this period, we no longer recruit participants untilnew information is released. Clinical Trials Recruiting Participants. What Can We Help With? Currently we have one US Clinical trial that is enrolling patients with NYHA Classification II and III. Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure (ZS-01-210). Please refer to this study by its ClinicalTrials.gov identifier: NCT01251406.
TOTAL LINKS TO THIS WEBSITE
14
ZEN MARTIAL ARTS SUMMER CAMP IN OTTAWA
ZEN MARTIAL ARTS SUMMER CAMP. I want to remember the great times I had at summer camp. As some of the best times of my life. Spending all day with my friends and making new friends is awesome. When I arrived for the first day of Zen Summer Camp. 6 to 12 years old. Some pictures from our previous camps. Camp Dates and Times. When I grow up. Summer Camp Special Offer*. Purchase more than one week and receive a free two month adult membership at Zen Martial Arts and Fitness*.
Zenkeep
Zensumo.com
Хостинг Обыкновенный, бесплатно: Страница не найдена
Успешно работает с августа 2005 года. Страница не найдена (404). Запрошенная страница http:/ zensumy.ho.com.ua. Не найдена на этом сервере, потому что домен zensumy.ho.com.ua. Не указывает ни на один виртуальный сервер. Если Вы являетесь владельцем этого домена, то Вы можете узнать, как настроить Ваш Хостинг Обыкновенный, в разделе FAQ. Пожалуйста, обращайтесь к администратору по адресу support@ho.ua. Размести свой сайт на ho! Это надежный платный и бесплатный хостинг.
上海至盛信息技术有限公司
泽生科技
Recombinant human neuregulin-1(NEUCARDIN : rhNRG-1). 联系电话 86-21-50802627 传真 86-21-50802621. 今日访问量 52 总访问量 46501.
正商地产首页
此页面上的内容需要较新版本的 Adobe Flash Player。 此页面上的内容需要较新版本的 Adobe Flash Player。 此页面上的内容需要较新版本的 Adobe Flash Player。
中国助产工具营销中心-专注于导乐球_导乐球架_分娩凳_导乐车_进口导乐工具销售研发
产前使用导乐球的好处 1. 增加血液流量到子. 详细. 电话 15725980266 值班电话 17862239026 E-mail 3100221051@qq.com.
Zensun's Blog | Just another WordPress.com weblog
Just another WordPress.com weblog. This blog exists…. April 12, 2009. Only because some blogs seem to require an external account to post on them. Annoying, that. April 12, 2009. Welcome to WordPress.com. This is your first post. Edit or delete it and start blogging! Create a free website or blog at WordPress.com.
zen sundays
Recovering food addict. retro-fitted hippie. joyful girl. Sunday, June 09, 2013. So, I've been working the program for a little over four months now. I'm on my 9th step and have lost 54 pounds. I'm feeling pretty darn good, physically and spiritually, and I'm looking forward to seeing where this journey takes me. Monday, April 22, 2013. 3500 of student loans/debt paid off. Not a bad semester. Tuesday, March 26, 2013. Monday, March 25, 2013. What should I do to celebrate? Tuesday, March 12, 2013. We have ...
香港赛马会唯一_香港赛马会官方网_香港赛马会开奖官方
